tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
XASE:LCTX
US Market

Lineage Therap (LCTX) Cash flow

Compare
2,046 Followers

Lineage Therap Cash Flow

LCTX's free cash flow for Q4 2025 was $-4.99M. For the 2025 fiscal year, LCTX's free cash flow was decreased by $4.22M and operating cash flow was $-4.88M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -18.92M$ -23.09M$ -28.57M$ 1.06M$ -23.56M
Investing Cash Flow
$ -13.46M$ -2.31M$ 46.45M$ -46.16M$ 9.74M
Financing Cash Flow
$ 26.95M$ 35.86M$ 6.42M$ 1.63M$ 36.93M
End Cash Position
$ 41.32M$ 46.35M$ 35.99M$ 11.94M$ 56.28M
Free Cash Flow
$ -19.44M$ -23.66M$ -29.24M$ 646.00K$ -23.91M
Currency in USD

Lineage Therap Cash Flow